ORGANOGENESIS HOLDINGS INC. Cash
ORGANOGENESIS HOLDINGS INC. (ORGO) had Cash of $102.24 million as of 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2021-11-09
- 2021-09-30: Cash $102.24M.
- 2021-06-30: Cash $89.79M.
- 2021-03-31: Cash $77.46M.
- 2020-12-31: Cash $84.39M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2021-09-30 | $102.24M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $89.79M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $77.46M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $84.39M 10-Q · filed 2021-11-09 | |
| 2020-09-30 | $36.51M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $40.45M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $46.90M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $60.17M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $22.97M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $20.04M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $30.56M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $21.29M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $2.71K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $64.41K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $99.49K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.31M 10-K · filed 2019-03-18 | $125.89K 10-K · filed 2018-03-14 |
| 2017-09-30 | $117.73K 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $286.46K 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $486.20K 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $1.04M 10-Q · filed 2018-11-09 | |
| 2016-09-30 | $171.83K 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $106.06K 10-Q · filed 2017-08-11 | |
| 2016-03-31 | $105.82K 10-Q · filed 2017-05-12 | |
| 2015-12-31 | $126.06K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |